Qingdao Sino-Cell Biomedicine Co., Ltd.
Privately held: no public share price · China
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | Autologous tumor neoantigens (polyclonal, patient-specific)Cell therapy | Non-Small Cell Lung CancerRenal Cell CarcinomaMelanoma Clear Cell Renal Cell Carcinoma |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.